Quotient Biodiagnostics develops and supplies transfusion diagnostic products and provides product development and manufacturing services to major transfusion diagnostic companies and the blood banking community. The Group highlights a track record of over 30 years ensuring safe and reliable blood transfusions. Alba Bioscience in Scotland serves as the product development and manufacturing arm, while Quotient Biodiagnostics, Inc. handles North American sales and marketing. Quotient plans to use new capital to grow US commercial operations, expand manufacturing and product development in Edinburgh, and accelerate development of a next‑generation automated transfusion diagnostics platform. The company completed an $11.2 million growth equity financing led by Galen Partners. Galen will take board seats and the company added an additional non‑executive director as part of the transaction.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2012